Screening in Contract Design: Evidence from the ACA Health Insurance Exchanges
NBER Working Paper No. 22832
Issued in November 2016, Revised in October 2017
NBER Program(s):AG, HC, HE, PE
We study insurers’ use of prescription drug formularies to screen consumers in the ACA Health Insurance Exchanges. We begin by showing that Exchange risk adjustment and reinsurance succeed in neutralizing selection incentives for most, but not all, consumer types. A minority of consumers, identifiable by demand for particular classes of prescription drugs, are predictably unprofitable. We then show that contract features relating to these drugs are distorted in a manner consistent with multi-dimensional screening. The empirical findings support a long theoretical literature examining how insurance contracts offered in equilibrium can fail to optimally trade-off risk protection and moral hazard.
The NBER Bulletin on Aging and Health provides summaries of publications like this.
You can sign up to receive the NBER Bulletin on Aging and Health by email.
Acknowledgments and Disclosures
Machine-readable bibliographic record -
Document Object Identifier (DOI): 10.3386/w22832
Users who downloaded this paper also downloaded* these:
|Deryugina, Heutel, Miller, Molitor, and Reif
||w22796 The Mortality and Medical Costs of Air Pollution: Evidence from Changes in Wind Direction
|Ho, Pakes, and Shepard
||w22835 The Evolution of Health Insurer Costs in Massachusetts, 2010-12
|Colla, Bynum, Austin, and Skinner
||w22826 Hospital Competition, Quality, and Expenditures in the U.S. Medicare Population
|Shen and Hsia
||w22861 Geographical Distribution of Emergency Department Closures and Consequences on Heart Attack Patients
|Davis, Haltiwanger, Jarmin, Lerner, and Miranda
||w17399 Private Equity and Employment